Fmr LLC Oramed Pharmaceuticals Inc. Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Fmr LLC holds 500 shares of ORMP stock, worth $1,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Holding current value

$1,190

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.06 - $2.7 $1,030 - $1,350	500 New	500 $1,000
Q4 2024 Feb 13, 2025	BUY	$2.17 - $2.52 $434 - $504	200 Added 13.33%	1,700 $4,000
Q3 2024 Nov 13, 2024	BUY	$2.21 - $2.63 $3,315 - $3,945	1,500 New	1,500 $3,000
Q3 2023 Nov 13, 2023	BUY	$2.51 - $3.55 $2,259 - $3,195	900 New	900 $2,000
Q1 2023 May 11, 2023	SELL	$1.93 - $13.1 $70,031 - $475,346	-36,286 Reduced 96.29%	1,400 $3,000

Q3 2022 Nov 10, 2022	SELL	$4.6 - $9.91 $212,386 - $457,554	-46,171 Reduced 55.06%	37,686 $244,000
Q2 2022 Aug 12, 2022	BUY	$3.72 - $9.0 $132,048 - $319,473	35,497 Added 73.4%	83,857 $384,000
Q1 2022 May 13, 2022	BUY	$8.19 - $13.89 $396,068 - $671,720	48,360 New	48,360 $418,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account